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E. Kalodiki*Vascular Unit, Ealing Hospital, London, UKThe fifth meeting of the European Venous Forum
(EVF) was held recently in Warsaw from the 25th to
the 27th of June with great success. The meeting was
attended by 230 delegates (compared to 100 of the 4th
meeting) and the forum has now 208 members
(compared to 164 in 2003).
The EVF was founded in 2000 in parallel with the
American Venous Forum with the aim of presenting
selected papers on venous disease of high scientific
quality. The peculiarity of these fora is that the
speakers are given 10 min to present their work
which is then followed by 10 min discussion.
The president of each forum with his team,
undertake to organize the congress locally. However,
the registration, selection of papers and printing of the
scientific program is done centrally from the organiz-
ing committee of the EVF whose president is Professor
A.N. Nicolaides.
The first congress was held in Lyon, France having
as president and organizer M. Perrin. The second took
place in Rome, by C. Allegra, the third in Berlin by U.
Schultz-Ehrenburg and the fourth in Lisbon by J.
Fernandes e Fernandes. The president and organizer
of the present one was A. Jawien. The sixth will take
place in 2005 in Crete with president and organizer A.
Katsamouris.
One of the advantages of being a member of the
EVF (annual membership 55 Euro i.e. £37) is that the
registration fee is very low for members (this year it
was 300 Euro i.e. £220 compared to 460 Euro i.e. £320
for non-members).
The scientific programme commenced on Friday
afternoon with two didactic sessions organized
together with the Polish Phlebological Society.iki, 6 Leinster Square, London W2 4PL, UK.
: e.kalodiki@imperial.ac.uk.
0101+ 03/0In the first session, on venous thromboembolism
chaired by W. Tomkowski and A. Jawien, J.A. Caprini
presented a paper on ‘risk assessment models’. W.
Tomkowski talked on ‘focus on prophylaxis of VTE’,
while the ‘management and treatment at the begin-
ning of the XXI century’ ‘for DVTand PE’ was covered
by A. Gallus and B. Davidson, respectively.
In the second session on chronic venous insuffi-
ciency (CVI), chaired by A. Nicolaides and A. Jawien,
the latter presented a paper on the ‘epidemiology and
genetic factors influencing CVI’, W. Olszewski out-
lined ‘The role of the lymphatic system in CVI’, and A.
Nicolaides talked on ‘from symptoms to leg edema:
efficacy of daflon 500 mg in CVI’. The guest of honour
this year was P. Gloviczki from USAwho reported on
the American Venous Forum guidelines on the
management of chronic venous disease.
Thirty-one abstracts were selected for presentation
and they appear below. The prizes were given to
numbers 20, 17 and 23. The prize apart from the
certificate (and a bottle of Vodka to celebrate it!)
provides the authors with a recommendation letter for
the scientific journal of their choice.
Session 1
CHRONIC VENOUS DISEASE
Chairmen: Andrew Nicolaides, Arkadiusz Jawien
1 Chronic venous disease: Care impact
Guex JJ(1), Myon E(2), Didier L(3), Marionneau N(2),
Taieb C(2)
(1)Head of Societe Francaise de Phlebologie, (2)Public
Health, Health Economics and Quality of Life Dept,
and ‘UTILES’ GP, (3)Laboratoires Pierre Fabre,
Investigators
2 Obesity as risk factor of chronic venous
diseases—The Bonn Vein Study
Rabe E(1), Pannier-Fischer F(1), Bock E(2), Stang
A(2), Bromen K(2), Jockel KH(2)
(1)Klinik und Poliklinik fur Dermatologie, Rheinische
Friedrich-Wilhelms Universitat, Bonn, (2)Institut fur
Medizinische Informatik, Biometrie und Epidemiologie
(IMIBE), Universitat EssenEJVES Extra 8, 101–103 (2004)
doi:10.1016/j.ejvsextra.2004.09.004, available online at http://www.sciencedirect.com on
E. Kalodiki1023 Comparative evaluation of quality of life in
chronic venous disease
Chassany O(1), Le Jeunne P(2)
(1)Clinical Research Delegation, Hopital Saint Louis,
Paris, (2)Thales Medical Observation Center, Boulogne
Billancourt, (3)Alfis: Association des Laboratoires et des
Firmes de Sante (French Association of Health
Companies)
4 Change in the quality of life in patients with
chronic venous disease: results of a 6 month
study using Daflon 500 mg
Arnould B(1), Regnault A(1), Perrin M(2)
(1)MAPI Values, 27 rue de la Villette, Lyon, France,
(2)26 Chemin de Decines, Chassieu, France
5 Physiological behaviour of calf muscle pump
function from childhood to adulthood as
determined by a 20 year prospective longitudinal
study (BOCHUM Study I–V)
Schultz-Ehrenburg U(1), Reich S(2), Robak-
Pawelczyk B(2), Weindorf N(3), Altmeyer P(2),
Stucker M(2)
(1)Health Center of Berlin-Weissensee, Dermatology
and Phlebology, Berlin, Germany, (2)Department of
Dermatology and Allergology, St Josef Hospital, Ruhr-
University, Bochum, Germany, (3)Department of
Dermatology and Allergology, St Elisabeth Hospital,
Oberhausen, Germany
6 The efficacy of a new portable sequential
compression device (SCD Expresse) in pre-
venting venous stasis
Kakkos SK(1,2) Griffin M(1), Geroulakos G(1,2),
Nicolaides AN(1,2)
(1)Department of Vascular Surgery, Faculty of Medi-
cine, Imperial College, (2)Ealing Hospital, London, UK
Session 2
DEEP VENOUS THROMBOSIS, COMPRESSION
Chairmen: Alun Davies, Walerian Staszkiewicz
7 The value of colour coded ultrasonography
versus D-dimer test in the diagnosis of recurrent
DVT: An inter-observer study
Madycki G, Staszkiewicz W, Dabek P, Gabrusie-
wicz A
Department of Vascular and General Surgery, Centre
for Postgraduate Medical Studies, Bielanski Hospital,
Ul Ceglowska 80, 01 809 Warsaw, Poland
8 A comparison between long term results of
catheter-directed thrombolysis and anticoagu-
lants in the treatment of acute iliofemoral deep
vein thrombosis
Markevicius N, Apanavicius G, Scerbinskas S,
Triponis V
Vilnius University, Clinic of Vascular Surgery,
Lithuania
9 Post-thrombotic syndrome after proximal DVT:
Can we avoid it?
Ziaja D, Urbanek T, Biolik G, Kostyra J, Ziaja D,
Kucharzewski M
Department of General and Vascular Surgery, Medical
University of Silesia, Katowice, Poland
10 Compression stockings reduce occupational leg
swelling
Partsch H(1), Winiger J(2), Lun B(3)
(1)Department of Dermatology, University of Vienna,
Austria, (2)Medical and Institutional Relations,
Ganzoni Management AG, Winterthur, Switzerland,
(3)Research Department of Ganzoni Group, St Just,
France
11 Superimposition of elastic compression stock-
ings: Resting and working pressures
Benigni J-P, Blin E, Schadeck M
Hopital Begin, Saint Mande, FranceEJVES Extra Vol 8, November 200412 Is superficial vein thrombosis benign? A meta-
analysis
Giannoukas AD(1), Leon L(2), DoddD(1), Chan P(1),
Labropoulos N(2)
(1)Sheffield Vascular Institute, Northern General
Hospital, Sheffield, UK, (2)Division of Vascular
Surgery, Loyola University Medical Center, Maywood,
Il, USA
BOARD MEETING
Session 3
SCLEROTHERAPY, QUALITY OF LIFE, MIS-
CELLANEOUS
Chairmen: Michel Perrin
13 Trans-catheter (short or long) foam sclerotherapy
in the treatment of varicose veins
Tessari L
Italy
14 Prospective randomised study of ultrasound
guided foam sclerotherapy and adjuvant high
tie under local anaesthesia versus conventional
surgery for primary varicose veins. Early results
Bountouroglou DG, Azzam M, Kakkos SK,
Pathmarajah M, Young P, Geroulakos G
Vascular Unit, Department of Vascular Surgery,
Ealing Hospital, Imperial College, London, UK
15 Cost benefits and quality of life changes after
superficial venous surgery in venous ulceration:
1 year results from the ESCHAR trial
Whitman B, Gohel MS, Barwell JR, Davies C,
Taylor M, Heather BP, Whyman MR, Poskitt KR,
Earnshaw JJ
Cheltenham General and Gloucestershire Royal Hos-
pitals, UK
16 Evolution of the initially competent greater
saphenous vein remnant after knee level limited
stripping: A 5 year follow-up study
Kostas T, Ioannou CV, Touloupakis E, Kafetzakis
A, Giarmenitis S*, Katsamouris AN
Division of Vascular Surgery and *Dept of Radiology,
University Hospital of Heraklion, University of Crete
Medical School, Heraklion, Crete, Greece
17
2nd PRIZE
Contraindication for pelvic varices embolisation
due to anomalies in the iliocaval sector
Leal Monedero J, Zubicoa Ezpeleta S, Castro
Castro J, Sanchez Guerrero A, Grimberg M
Hospital Ruber Internacional, La Maso 38, 28034,
Madrid, Spain
18 Incompetent saphenous vein treatment by
endovenous laser and radiofrequency. A litera-
ture updated review
Perrin M
Vascular Surgery, Institution Clinique du Grand
Large, Lyon, France
ANNUAL GENERAL MEETING
Session 4
INCOMPETENT PERFORATORS, RECURRNCE
OF VARICOSE VEINS, SEGMENTAL APLASIA
Chairmen: Eberhard Rabe, Jaroslav Strejcek
19 Perforator of the popliteal fossa and short
saphenous insufficiency
De Palma M, Mazza P, Carandina S, Fortini P,
Legnaro A, Palazzo A, Liboni A, Zamboni P
Department of Surgery and Vascular Laboratory,
University of Ferrara, Italy
20 Re-entry ways in varicose disease3
1st PRIZE Winczakiewicz J, Borkiewicz M
Prywatne Centrum Chirurgii, Torun, Poland
21 A summation analysis of incompetent saphe-
nopopliteal ligation after short saphenous vein
surgery
Tsang FJ, Davis M, Davies AH
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Hospital, London, UK
22 Relationship between the calibre of the greater
saphenous vein and the competence or absence/
incompetence of the femoral valve in subjects
with incompetence of the sapheno-femoral
junction
Cappelli M(1), Molino Lova R(2), Ermini S(3),
Zamboni P(4)
(1)Phlebologic Surgery, Via Datini 46, Florence, Italy,
(2)Don Gnocchi Foundation, Pozzolatico, Florence,
(3)Phlebologic Surgery, Via Tizzano 1, Grassina,
Florence, (4)Department of Surgery and Vascular
Laboratory, University of Ferrara, Italy
23
3rd PRIZE
Saphenofemoral venous channels associated
with recurrent varicose veins are not neovascular
El Wajeh(1), Giannoukas AD(1), Gulliford CJ(2),
Suvarna SK(2), Chan P(1)
(1)Sheffield Vascular Institute, (2)Department of His-
topathology, Northern General Hospital, Sheffield, UK
24 Segmental aplasia of the great saphenous vein
and varicose veins
Caggiati A(1), Mendoza E(2)
(1)Department of Anatomy, University “La Sapienza”,
Rome, Italy and (2)Private Office, Wunstorf, Germany
Session 5
MOLECULAR BIOLOGY OF THE VENOUS
WALL, LEG ULCERS, A FORGOTTEN ENTITY
Chairmen: Zhigniew Rybak, John Hobbs
25 Assessment of matrix metalloproteinases in the
vein wall
Kowalewski R(1), Gacko M(1), Sobolewski K(2),
Wolanska M(2), Glowinski J(1), Guzowski A(1),
Panek B(1)
(1)Dpt of Vascular Surgery and Transplantology, (2)Dpt
of Medical Biochemistry, Medical University, Bialystok,
Poland
26 MMP9 in chronic venous disease and venous leg
ulcers
Zamboni P(1), Izzo M(1), Lanzara S(1), Mazza P(1),
Carandina S(1), De Palma M(1), Fortini P(1),
Legnaro A(1), Palazzo A(1), Lanzara V(2)
(1)Dpt of Surgery and Vascular Laboratory, (2)Dpt of
Biochemistry and Molecular Biology, University of
Ferrara, Italy27 Sex hormone in varicose veins of women with
premenstrual syndrome
Krasinski Z, Szczesniak-Chmielecka A, Dzieciu-
chowicz L, Krasinska B, Chmielecki J, Oszkinis G,
Brazert J
Poland
28 Conservative versus surgical treatment of
venous leg ulcers (Dutch SEPS trial)
Wittens CHA, van Gent WB, Hop WCJ
Holland
29 Haemodynamic assessment predicts healing
and recurrence in chronic venous leg ulceration
Gohel MS, Barwell JR, Wakely C, Minor J, Harvey
K, Sassano A, Taylor M, Heather BP, Earnshaw JJ,
Mitchell DC, Whyman MR, Poskitt KR
Cheltenham General, Gloucestershire Royal and
Southmead Hospitals, UK
30 Management of venous stasis ulcer with the
compass technique
Eaton TL(1), McDonagh B(2), GuptanRC(3)
(1)Wisconsin Phlebology Medical Group, Brookfield,
Wisconsin, USA, (2)Illinois Phlebology Group, Chicago,
Illinois, USA, (3)Department of Clinical Research,
Venous Research Foundation, Schaumberg, Illinois,
USA
31 PaGet von Schroetter syndrome: An entity
forgotten in the district
Fassiadis N(1), Theodorides A(2), Roidl M(1),
Geroulakos G(2), South LM(1)
(1)Maidstone Hospital, Kent, UK, (2)Ealing Hospital,
London, UKThe Gala dinner took place at the magnificent
Palace on the Water, at the Warsaw Lazienki Park and
it was followed by a concert by the famous Polish
Chamber Singers Affabre Concinui. The organizers
did a great job to look after their guests and the
pharmaceutical companies supported the meeting
generously.
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